Abstract
ABSTRACTOmicron, the most recent SARS-CoV-2 variant of concern (VOC), harbours multiple mutations in the spike protein that were not observed in previous VOCs. Initial studies suggest Omicron to substantially reduce the neutralizing capability of antibodies induced from vaccines and previous infection. However, its effect on T cell responses remains to be determined. Here, we assess the effect of Omicron mutations on known T cell epitopes and report data suggesting T cell responses to remain broadly robust against this new variant.
Publisher
Cold Spring Harbor Laboratory
Reference17 articles.
1. The T-Cell Response to SARS-CoV-2: Kinetic and Quantitative Aspects and the Case for Their Protective Role;Oxford Open Immunology,2021
2. Deng, Yao , Yu Li , Ren Yang , and Wenjie Tan . 2021. “SARS-CoV-2-Specific T Cell Immunity to Structural Proteins in Inactivated COVID-19 Vaccine Recipients.” Cellular & Molecular Immunology, no. June (July): 1–2. https://doi.org/10.1038/s41423-021-00730-8.
3. Early cross-coronavirus reactive signatures of humoral immunity against COVID-19
4. Hannah Ritchie Edouard Mathieu , Lucas Rodés-Guirao Cameron Appel Charlie Giattino Esteban Ortiz-Ospina Joe Hasell Bobbie Macdonald Diana Beltekian , and Max Roser . 2020. “Coronavirus Pandemic (COVID-19).” Our World in Data.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献